Author:
Villavicencio R. T.,Harbrecht B. G.,Billiar T. R.
Publisher
Springer Berlin Heidelberg
Reference105 articles.
1. Aneman A, Backman V, Snygg J, Bothmer CV, Fandricks L, Pettersson A (1995) Accululation of an endogenous inhibitor of nitric oxide synthase during graded hemorrhagic shock. Circulatory Shock 44:111–114
2. Anzueto A, McLucki A, Holzapfel L, Grove G, Mottola D, Takala J (1997) Multicentre, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88 in patients with septic shock: safety profile. Chest 112:88S
3. Aoki N, Johnson G, Lefer AM (1990) Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol 258:G275–G281
4. Aranow JS, Zhuang J, Wang H, Larkin V, Smith M, Fink MP (1996) A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: comparison with two nonselective strategies. Shock 5:116–121
5. Barthlen W, Stadler J, Lehn NL, Miethke T, Bartels H, Siewart JR (1994) Serum levels of end products of nitric oxide synthesis correlate positively with tumor necrosis factor-α and negatively with body temperature in patients with postoperative abdominal sepsis. Shock 2:398–401